Amplified Sciences Secures Investment From AGA GI Opportunity Fund in Seed+ Round

Deal Summary

Amplified Sciences, a clinical-stage diagnostics company, announced a new investment from the American Gastroenterological Association’s GI Opportunity Fund as part of its Seed+ financing round, led by OCA Ventures with participation from other institutional investors. The undisclosed funding will support a pivotal real-world observational study, expand commercial partnerships, and broaden market access for its PanCystPro assay.